VRAX
Virax Biolabs Group LtdCompany with tickers: VRAX
CIK
1885827
CUSIP
G9495L125
Shares Outstanding
7,423,432
Website
https://viraxbiolabs.com
Investor Relations
https://ir.viraxbiolabs.com/
13F Activity (30d)
2 filings
2 filers
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2022-07-26 | — | |
| 6-K | 2022-07-29 | — | |
| 20-F | 2022-08-12 | 2022-03-31 | |
| 6-K | 2022-09-07 | — | |
| 6-K | 2022-09-12 | — | |
| 6-K | 2022-09-20 | — | |
| 6-K | 2022-09-22 | — | |
| 6-K | 2022-10-26 | — | |
| 6-K | 2022-11-03 | — | |
| 6-K | 2022-11-08 | — | |
| 6-K | 2022-11-15 | — | |
| 6-K | 2022-11-18 | — | |
| 6-K | 2022-12-06 | — | |
| 6-K | 2023-01-04 | — | |
| 6-K | 2023-02-02 | — | |
| 6-K | 2023-02-07 | — | |
| 6-K | 2023-03-07 | — | |
| 6-K | 2023-03-10 | — | |
| 6-K | 2023-04-19 | — | |
| 6-K | 2023-04-21 | — | |
| 6-K | 2023-05-04 | — | |
| 20-F | 2023-06-14 | 2023-03-31 | |
| 6-K | 2023-06-14 | — | |
| 6-K | 2023-07-18 | — | |
| 6-K | 2023-08-03 | — | |
| 6-K | 2023-09-01 | — | |
| 6-K | 2023-09-12 | — | |
| 6-K | 2023-10-04 | — | |
| 6-K | 2023-10-12 | — | |
| 6-K | 2023-10-31 | — | |
| 6-K | 2023-11-08 | — | |
| 6-K | 2023-12-08 | — | |
| 6-K | 2023-12-14 | — | |
| 6-K | 2023-12-18 | — | |
| 6-K | 2023-12-20 | — | |
| 6-K | 2023-12-21 | — | |
| 6-K | 2024-01-12 | 2024-01-11 | |
| 6-K | 2024-01-22 | — | |
| 6-K | 2024-03-15 | — | |
| 6-K | 2024-04-16 | — | |
| 6-K | 2024-04-25 | — | |
| 6-K | 2024-06-11 | — | |
| 20-F | 2024-08-20 | 2024-03-31 | |
| 6-K | 2024-08-23 | — | |
| 6-K | 2024-09-30 | — | |
| 6-K | 2024-10-23 | — | |
| 6-K | 2024-10-31 | — | |
| 6-K | 2024-11-20 | — | |
| 6-K | 2024-12-10 | — | |
| 6-K | 2024-12-17 | — |
Showing 1–50 of 67 filings